Tumor-derived DEFB1 induces immune tolerance by inhibiting maturation of dendritic cell and impairing CD8+ T cell function in esophageal squamous cell carcinoma

Jingjing Duan, Haotian Wang, Minglu Liu, Yin Chen, Ning Li, Jieqiong Liu, Lingxiong Wang, Lin Li, Yaru Liu, Pengfei Dong, Xiuxuan Wang, Zhongyi Fan, Shunchang Jiao

2024, 36(4): 351-367. doi: 10.21147/j.issn.1000-9604.2024.04.01

A pilot clinical study to evaluate feasibility of using single patient classifier as a prognostic test in stage II−III gastric cancer patients

Ji Yeong An, Sung Eun Oh, Soomin Ahn, Hyoung-II Kim, Yoo Min Kim, Minah Cho, Keun Won Ryu, Hong Man Yoon, Young Kyu Park, In Gyu Kwon, Sung Hoon Noh, Kyung Hee Lee, In Cho, Myoung Won Son, Jong Won Kim, Young-Woo Kim

2024, 36(4): 368-377. doi: 10.21147/j.issn.1000-9604.2024.04.02

SOX11 as a potential prognostic biomarker in hepatocellular carcinoma linked to immune infiltration and ferroptosis

Hongyu Chen, Qiangguo Ao, Yueling Wang, Yue Qian, Qingli Cheng, Wei Zhang

2024, 36(4): 378-397. doi: 10.21147/j.issn.1000-9604.2024.04.03

Efficacy and safety of dacomitinib as first-line treatment for advanced non-small cell lung cancer patients with epidermal growth factor receptor 21L858R mutation: A multicenter, case-series study in China

Shouzheng Wang, Jiayu Liu, Yan Wang, Ying Hu, Ziling Liu, Yu Yao, Li Liang, Yutao Liu, Lin Wang, Junling Li, Puyuan Xing

2024, 36(4): 398-409. doi: 10.21147/j.issn.1000-9604.2024.04.04

Neoadjuvant chemotherapy with capecitabine combined with oxaliplatin for mid-low locally advanced rectal cancer with negative mesorectal fascia: Long-term outcomes of a prospective trial (PKUCH-R03 trial)

Nan Chen, Minghe Zhao, Yunfeng Yao, Lin Wang, Yifan Peng, Tingting Sun, Tiancheng Zhan, Jun Zhao, Aiwen Wu

2024, 36(4): 410-420. doi: 10.21147/j.issn.1000-9604.2024.04.05

Immune status and combined immunotherapy progression in Kirsten rat sarcoma viral oncogene homolog (KRAS)-mutant tumors

Dongsheng He, Rilan Bai, Naifei Chen, Jiuwei Cui

2024, 36(4): 421-441. doi: 10.21147/j.issn.1000-9604.2024.04.06

Potential value of detection of minimal residual disease in colorectal cancer following radical resection

Wenji Pu, Fang Chen, Yuan Tang, Yanling Qu, Yunzhu Han, Jiandong Zha, Jing Jin, Fengming Kong

2024, 36(4): 442-454. doi: 10.21147/j.issn.1000-9604.2024.04.07